SG11201607893TA - Hemostatic pharmaceutical composition - Google Patents

Hemostatic pharmaceutical composition

Info

Publication number
SG11201607893TA
SG11201607893TA SG11201607893TA SG11201607893TA SG11201607893TA SG 11201607893T A SG11201607893T A SG 11201607893TA SG 11201607893T A SG11201607893T A SG 11201607893TA SG 11201607893T A SG11201607893T A SG 11201607893TA SG 11201607893T A SG11201607893T A SG 11201607893TA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
hemostatic pharmaceutical
hemostatic
composition
pharmaceutical
Prior art date
Application number
SG11201607893TA
Inventor
Hayato Saijo
Hirofumi Ochiai
Taiji Shimoda
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of SG11201607893TA publication Critical patent/SG11201607893TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
SG11201607893TA 2014-03-28 2014-08-06 Hemostatic pharmaceutical composition SG11201607893TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014068333 2014-03-28
PCT/JP2014/070703 WO2015145797A1 (en) 2014-03-28 2014-08-06 Hemostatic pharmaceutical composition

Publications (1)

Publication Number Publication Date
SG11201607893TA true SG11201607893TA (en) 2016-11-29

Family

ID=54194377

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201808583SA SG10201808583SA (en) 2014-03-28 2014-08-06 Hemostatic pharmaceutical composition
SG11201607893TA SG11201607893TA (en) 2014-03-28 2014-08-06 Hemostatic pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201808583SA SG10201808583SA (en) 2014-03-28 2014-08-06 Hemostatic pharmaceutical composition

Country Status (9)

Country Link
US (1) US20170119844A1 (en)
EP (1) EP3124058A4 (en)
JP (1) JPWO2015145797A1 (en)
KR (1) KR20160142843A (en)
CN (1) CN106659821A (en)
AU (1) AU2014388585B2 (en)
CA (1) CA2943734A1 (en)
SG (2) SG10201808583SA (en)
WO (1) WO2015145797A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943763B2 (en) * 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
US9327010B2 (en) * 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
JP2007217376A (en) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology Self-assembly peptide composition
CA2680824C (en) * 2007-03-14 2018-06-26 Arch Therapeutics, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
CN105435211A (en) * 2008-10-06 2016-03-30 三维肽胶株式会社 Tissue plug
CN101514225B (en) * 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 Self-polymerization polypeptide and preparation method and application thereof
CA2908136C (en) * 2013-03-30 2021-06-29 Glytech, Inc. Sugar chain-polypeptide complex

Also Published As

Publication number Publication date
AU2014388585A1 (en) 2016-10-27
CA2943734A1 (en) 2015-10-01
EP3124058A4 (en) 2017-11-29
US20170119844A1 (en) 2017-05-04
SG10201808583SA (en) 2018-11-29
KR20160142843A (en) 2016-12-13
AU2014388585B2 (en) 2018-10-04
EP3124058A1 (en) 2017-02-01
WO2015145797A1 (en) 2015-10-01
JPWO2015145797A1 (en) 2017-04-13
CN106659821A (en) 2017-05-10

Similar Documents

Publication Publication Date Title
HK1225655A1 (en) Pharmaceutical compositions comprising azd9291
GB201618482D0 (en) Pharmaceutical compositions
GB201419257D0 (en) Pharmaceutical compositions
GB201409471D0 (en) Pharmaceutical composition
IL249553A0 (en) Pharmaceutical compositions
SG11201605366QA (en) Pharmaceutical composition containing pyridylaminoacetic acidcompound
GB201409485D0 (en) Pharmaceutical composition
GB201409488D0 (en) Pharmaceutical composition
EP3141243A4 (en) Pharmaceutical composition
GB201521462D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
ZA201502073B (en) Pharmaceutical composition
IL250817A0 (en) Pharmaceutical compositions
ZA201508726B (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
PL3200772T3 (en) Pharmaceutical compositions comprising alpelisib
EP3170512A4 (en) Pharmaceutical composition
LT3089740T (en) Pharmaceutical composition
SG11201608123VA (en) Pharmaceutical composition for external use
SG10201504332VA (en) Pharmaceutical Composition
SG11201608124XA (en) Pharmaceutical composition for external use
SG11201607893TA (en) Hemostatic pharmaceutical composition
GB201521456D0 (en) Pharmaceutical composition
GB201516183D0 (en) Novel pharmaceutical composition
SG11201608122PA (en) Pharmaceutical composition for external use